- Home
- ASLE vs PRQR Comparison
ASLE vs PRQR Comparison
Compare ASLE & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASLE | PRQR |
|---|---|---|
| Founded | 2008 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 290.0M | 250.7M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | ASLE | PRQR |
|---|---|---|
| Price | $6.71 | $2.13 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $7.00 | ★ $8.14 |
| AVG Volume (30 Days) | ★ 496.2K | 439.7K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $339,090,000.00 | $18,859,556.00 |
| Revenue This Year | $1.35 | N/A |
| Revenue Next Year | $19.09 | N/A |
| P/E Ratio | $59.26 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.56 | $1.07 |
| 52 Week High | $9.12 | $3.71 |
Technical Indicators
Market Signals| Indicator | ASLE | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 52.32 | 46.03 |
| Support Level | $6.33 | $1.91 |
| Resistance Level | $6.75 | $2.15 |
| Average True Range (ATR) | 0.22 | 0.17 |
| MACD | 0.11 | 0.01 |
| Stochastic Oscillator | 94.71 | 44.90 |
Price Performance
Historical ComparisonAbout ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.